ProPhase Labs, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders' Equity - Narrative (Details)

Stockholders' Equity - Narrative (Details) - USD ($)														12 Months Ended
Stockholders' Equity - Narrative (Details) - USD ($)	Dec. 19, 2025	Sep. 09, 2025	Feb. 17, 2025	Jan. 29, 2025	Nov. 21, 2024	Nov. 12, 2024	Apr. 15, 2024	Jan. 01, 2024	Jun. 03, 2022	May 19, 2022	Dec. 28, 2021	May 20, 2021	Apr. 12, 2018	Dec. 31, 2025	Dec. 31, 2024	Dec. 02, 2025	Sep. 08, 2025	Jun. 16, 2023	Jan. 03, 2023	May 09, 2022
Offsetting Assets [Line Items]
Common stock, authorized (in shares)		1,000,000,000												1,000,000,000	1,000,000,000		50,000,000
Common stock, par or stated value (in dollars per share)														$ 0.0005	$ 0.0005	$ 0.0005			$ 0.0005
Preferred stock, authorized (in shares)														1,000,000	1,000,000
Preferred stock, par or stated value (in dollars per share)														$ 0.0005	$ 0.0005
Preferred stock, issued (in shares)														0	0
Dividends declared														$ 0
Closing stock price (in dollars per share)														$ 0.45	$ 7.57
Offering cost														$ 275,000	$ 577,000
Warrants (in shares)														695,000
Issuance of common shares as collateral for a loan (in shares)														1,360,000
Issuance of treasury shares as collateral for a loan (in shares)					600,000
Shares issued (in shares)														185,000	184,000
Vesting period (in years)							4 years
Fair value of stock options granted														$ 480,000	$ 5,500,000
Estimated fair value of options at date of grant						$ 117,000
Share-based compensation expense														1,900,000	$ 3,600,000
Share-based compensation, nonvested award, cost not yet recognized, amount														$ 2,600,000
Weighted average period (in years)														2 years 8 months 12 days
Former Chief Operating Officer \| Inducement Option Award
Offsetting Assets [Line Items]
Shares issued (in shares)			50,000
Exercise price, lower range (in dollars per share)			$ 6.00
Award expiration period (in years)			7 years
Former Chief Operating Officer \| Inducement Option Award \| First Installment
Offsetting Assets [Line Items]
Award vesting rights (as a percent)			25.00%
Chief Operating Officer \| Inducement Option Award
Offsetting Assets [Line Items]
Shares issued (in shares)								50,000
Exercise price, lower range (in dollars per share)								$ 60.00
Award expiration period (in years)								7 years
Fair value of stock options granted								$ 1,300,000
Chief Operating Officer \| Inducement Option Award \| First Installment
Offsetting Assets [Line Items]
Award vesting rights (as a percent)								25.00%
Employee \| Inducement Option Award
Offsetting Assets [Line Items]
Shares issued (in shares)							5,000
Exercise price, lower range (in dollars per share)							$ 62.00
Award expiration period (in years)							7 years
Fair value of stock options granted							$ 201,000
Employee \| Inducement Option Award \| First Installment
Offsetting Assets [Line Items]
Award vesting rights (as a percent)							25.00%
Employee \| Inducement Option Award \| Third Installment
Offsetting Assets [Line Items]
Award vesting rights (as a percent)							25.00%
Employee \| Inducement Option Award \| Fourth Installment
Offsetting Assets [Line Items]
Award vesting rights (as a percent)							25.00%
Employee \| Inducement Option Award \| Second Installment
Offsetting Assets [Line Items]
Award vesting rights (as a percent)							25.00%
2025 Directors Plan
Offsetting Assets [Line Items]
Increase in the number of shares reserved for issuance (in shares)		50,000
Shares issued (in shares)														0
Shares authorized (in shares)														60,000
2022 Directors Plan
Offsetting Assets [Line Items]
Increase in the number of shares reserved for issuance (in shares)										30,000
Shares issued (in shares)														20,000	21,000
Future issuance (in shares)																	10,000
Amended 2022 Directors' Plan
Offsetting Assets [Line Items]
Increase in shares for issuance (in shares)																		15,000
Amended 2010 Directors' Plan
Offsetting Assets [Line Items]
Shares authorized (in shares)												77,500
2025 Plan
Offsetting Assets [Line Items]
Increase in the number of shares reserved for issuance (in shares)		300,000
Shares issued (in shares)														72,672
Shares authorized (in shares)														233,203
2022 Plan
Offsetting Assets [Line Items]
Shares issued (in shares)														42,329	108,000
Increase in shares for issuance (in shares)																				100,000
Future issuance (in shares)																	3,375
Amended 2010 Plan
Offsetting Assets [Line Items]
Common stock issued (in shares)
2018 Stock Incentive Plan \| CEO Options
Offsetting Assets [Line Items]
Exercise price, lower range (in dollars per share)									$ 6.00
2018 Stock Incentive Plan \| Chief Executive Officer
Offsetting Assets [Line Items]
Shares issued (in shares)													230,000
Public Offering
Offsetting Assets [Line Items]
Sale of stock, consideration received on transaction						$ 3,000,000.0
Number of shares of common stock sold (in shares)						479,500
Net of offering cost						$ 483,000
Closing stock price (in dollars per share)						$ 7.20
Sale of stock, consideration received on transaction, gross						$ 3,500,000
Warrant percentage						5.00%
Public Offering \| Representative's Warrants
Offsetting Assets [Line Items]
Warrants (in shares)						23,978
Exercise price (in dollars per share)						$ 9.00
Warrants outstanding, term (in years)						4 years 6 months
Number of days from commencement of warrant						180 days
Over-Allotment Option
Offsetting Assets [Line Items]
Number of shares of common stock sold (in shares)						62,500
Keystone \| Keystone ELOC Shares
Offsetting Assets [Line Items]
Aggregate offering price				$ 7,700,000
Issuance of common stock as commitment fee for future financing (in shares)				352,176
Issuance of common stock as commitment fee for future financing				$ 158,000
Sale of stock, consideration received on transaction														$ 3,600,000
Number of shares of common stock sold (in shares)														1,131,500
Net of offering cost														$ 433,000
Closing stock price (in dollars per share)														$ 2.90
Keystone \| Keystone ELOC Shares \| Treasury Stock
Offsetting Assets [Line Items]
Number of shares of common stock sold (in shares)														424,896
WestPark Capital, Inc. \| At the Market Offering
Offsetting Assets [Line Items]
Aggregate offering price	$ 5,300,000
Number of shares of common stock sold (in shares)														0
Sale of stock, commission percentage	3.00%
ThinkEquity LLC \| At the Market Offering
Offsetting Assets [Line Items]
Aggregate offering price											$ 100,000,000
Sale of stock, consideration received on transaction															$ 4,600,000
Number of shares of common stock sold (in shares)														0	1,033,500
Offering cost															$ 94,000